Trial · NCT05848375
Rotator Cuff Repair Under Isolated Loco-regional Anesthesia
NCT05848375, Not applicable, Unknown, Elsan
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Rotator Cuff Repair Under Isolated Loco-regional Anesthesia. Trials, record NCT05848375. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05848375
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Rotator Cuff Repair Under Isolated Loco-regional Anesthesia
- NCT number
- NCT05848375
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Elsan
- Conditions
- Shoulder Cuff Surgical Repair
- Interventions
- Arthroscopic rotator cuff repair, naropeine or chirocaine (Arthroscopic rotator cuff repair under LRA associated to GA), naropeine or chirocaine (Arthroscopic rotator cuff repair under LRA)
- First posted
- 2023-05-08
- Last updated
- 2024-06-13
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | compare systolic blood pressure (SBP) measured during surgery between patients operated for rotator cuff repair under LRA alone and those under LRA and GA. | Day 0 | The main evaluation criterion is the average systolic pressures, measured in the supine position, before loco-regional anesthesia, in the induction room, then in the prone position on entering the operating room, then in a semi-sitting position, and every 5 minutes during the surgery, the duration of which varies according to the patient between 30 and 45 minutes. The average of the systolic blood pressures will be calculated on the available data, with a minimum of 4 values. |
| Secondary | Hydraulic pressure during surgery | Day 0 | The difference in pressure administered by the arthrpomp between the beginning and the end of the surgery |
| Secondary | The intensity of bleeding during surgery | Day 0 | The intensity of bleeding during surgery, assessed by the number of washes performed |
| Secondary | Sedation administered to the patient during surgery | Day 0 | Sedation assessed by the type of sedation administered to the patient: no sedation, hypnotic sedation, morphine sedation |
| Secondary | Patient pain after surgery | Day 1 to day 21 | Pain is assessed by a visual analogue scale over 100 mm, measured morning and evening the first 3 days after surgery then once on day 7, day 14 and day 21 after surgery. |
| Secondary | Patient satisfaction 3 weeks after surgery | 3 weeks | Patient satisfaction on the surgery will be measured by a 4 point Likert scale and positive and negative points will be collected in comments |
| Secondary | Adverse events between patients operated on LRA alone and patients on LRA and GA. | Day 0 to 6 months | The number and type of adverse events noted during the procedure and in the 6 months post-operation. |
| Secondary | Medication taken for pain between these same groups of patients in the 21 days following surgery. | Day 1 to day 21 | The patient's daily consumption of painkillers will be recorded in a patient diary for 21 days after the intervention |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05848375
GET https://conductscience.org/api/trials/v1/NCT05848375/registered